Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy
Clinical trial NCT00891345 · COMPLETED
Trial details
- NCT number
- NCT00891345
- Sponsor
- CytoVac A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-07-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.